Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 88,311 | 84,512 | 415,484 | 93,855 | 291,342 |
| Cost of Goods | 36,669 | 60,619 | 46,242 | 59,209 | 154,976 |
| Gross Profit | 51,642 | 23,893 | 369,242 | 34,646 | 136,366 |
| Operating Expenses | 183,391 | 158,530 | 208,486 | 179,686 | 320,910 |
| Operating Income | -131,080 | -134,018 | 160,998 | -144,831 | -183,568 |
| Interest Expense | 7,585 | 4,236 | 4,143 | 4,111 | 4,117 |
| Other Income | 65,084 | 15,922 | 7,731 | 3,654 | 10,984 |
| Pre-tax Income | -73,581 | -122,332 | 164,586 | -145,288 | -176,701 |
| Income Tax | 7,449 | -1,032 | 2,205 | 2,262 | 1,688 |
| Net Income Continuous | -81,030 | -121,300 | 162,381 | -147,550 | -178,389 |
| Net Income | $-81,030 | $-121,300 | $162,381 | $-147,550 | $-178,389 |
| EPS Basic Total Ops | -0.51 | -0.76 | 1.09 | -1.05 | -1.39 |
| EPS Basic Continuous Ops | -0.51 | -0.76 | 1.09 | -1.05 | -1.38 |
| EPS Diluted Total Ops | -0.41 | -0.76 | 0.99 | -1.05 | -1.32 |
| EPS Diluted Continuous Ops | -0.40 | -0.76 | 0.98 | -1.05 | -1.29 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.76 | 0.99 | N/A | N/A |
| EBITDA(a) | $-118,563 | $-121,318 | $172,130 | $-132,684 | $-172,774 |